NRX Pharmaceuticals, Inc. - Common Stock (NQ:NRXP)

2.850 -0.040 (-1.38%)

Delayed Quote Updated: 4:00 PM EDT, Oct 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about NRX Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

NRX Pharmaceuticals Reports Q2 2026 Results: Full Earnings Call Transcript ↗

August 17, 2026

NRX Pharmaceuticals (NASDAQ:NRXP) released second-quarter financial results and hosted an earnings call on Monday. Read the complete transcript below. This content is powered by Benzinga APIs. For...

Via Benzinga

Topics Earnings

NRx Pharmaceuticals Nears FDA Decision on Preservative-Free Ketamine After Review Clears Hurdles ↗

August 10, 2026

NRx Pharmaceuticals (NASDAQ:NRXP) said it has completed the first-cycle U.S. Food and Drug Administration review of its abbreviated new drug application, or ANDA, for preservative-free ketamine, with...

Via MarketBeat

These stocks are moving in today's pre-market session ↗

June 03, 2026

Via Chartmill

What's going on in today's after hours session ↗

June 02, 2026

Via Chartmill

Why Did NRXP Stock Surge 21% Pre-Market Today? ↗

January 14, 2026

Via Stocktwits

Insights Ahead: NRX Pharmaceuticals's Quarterly Earnings ↗

August 13, 2025

Via Benzinga

HOPE Therapeutics Secures Financing For Ketamine Clinic Expansion ↗

August 26, 2024

HOPE Therapeutics, Inc., a subsidiary of NRx Pharmaceuticals, Inc. (NASDAQ: NRXP),

Via Benzinga

NRx (NRXP) Q1 2026 Earnings Call Transcript ↗

May 27, 2026

NRx (NRXP) Q1 2026 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Tuesday's session: top gainers and losers ↗

May 26, 2026

Via Chartmill

My Top 3 Biotech Stocks for May 2026 ↗

May 20, 2026

As FDA activity accelerates and big pharma searches for its next generation of blockbuster drugs, select biotech companies are beginning to stand out from the crowd.

Via The Motley Fool

Topics Artificial Intelligence Intellectual Property

NRx Pharmaceuticals Q1 Earnings Call Highlights ↗

May 18, 2026

NRx Pharmaceuticals (NASDAQ:NRXP) said it advanced several regulatory, manufacturing and clinical initiatives during the first quarter of 2026, including progress toward potential approval of its...

Via MarketBeat

Topics Earnings

Earnings Scheduled For November 17, 2025 ↗

November 17, 2025

Via Benzinga

Earnings Outlook For NRX Pharmaceuticals ↗

November 14, 2025

Via Benzinga

Alphabet To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Thursday ↗

October 30, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

August 22, 2025

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

August 19, 2025

Via Benzinga

Why Small-Cap Biotech NRx Pharmaceuticals Is Drawing Heavy Retail Buzz ↗

August 12, 2025

NRx said the FDA’s fast-track status makes NRX-100 eligible for the Commissioner’s National Priority Voucher program and the FDA’s Accelerated Approval pathway, and the company has already applied for...

Via Stocktwits

Uncovering Potential: NRX Pharmaceuticals's Earnings Preview ↗

May 14, 2025

Via Benzinga

Stocktwits Spotlight: NRx, CVS, ReShape Lead Weekly Jump In Health Care Stock Chatter ↗

May 04, 2025

Favorable regulatory moves for a new drug application, blowout earnings and promising preclinical data triggered a flurry of discussions on Stocktwits for these tickers for the week ended April 11,...

Via Stocktwits

Topics Intellectual Property Law Enforcement Lawsuit

Earnings Scheduled For May 15, 2025 ↗

May 15, 2025

Via Benzinga

Amazon.com To $253? Here Are 10 Top Analyst Forecasts For Tuesday ↗

April 29, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

March 17, 2025

Via Benzinga

Earnings Scheduled For March 17, 2025 ↗

March 17, 2025

Via Benzinga

Small-Cap NRx Pharma’s Stock Draws Heavy Retail Buzz After Securing $27M Funding ↗

January 29, 2025

Chairman Jonathan Javitt said the resources committed are expected to bring NRx to the $100 million revenue threshold.

Via Stocktwits

What's Going On With NRX Pharmaceuticals Stock Tuesday? ↗

January 28, 2025

NRX Pharmaceuticals shares are moving higher on Tuesday after it invested $27 million in its subsidiary HOPE Therapeutics.

Via Benzinga

What's Going On With NRX Pharmaceuticals Stock Thursday? ↗

January 02, 2025

NRX shares are trading higher on Thursday after the company announced a joint acquisition initiative with Hope Therapeutics to buy Kadima Neuropsychiatry Institute.

Via Benzinga

Why MicroStrategy Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket ↗

January 02, 2025

Shares of MicroStrategy Incorporated (NASDAQ:MSTR) rose sharply in today's pre-market trading.

Via Benzinga

NRXP Stock Earnings: NRX Pharmaceuticals Misses EPS for Q2 2024 ↗

August 14, 2024

NRXP stock results show that NRX Pharmaceuticals missed analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

May 16, 2024

Via Benzinga

NRXP Stock Earnings: NRX Pharmaceuticals Misses EPS for Q1 2024 ↗

May 14, 2024

NRXP stock results show that NRX Pharmaceuticals missed analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.